Top compounds associated with response to CLDN11


Feature Type Standardized
Nominal ANOVA
mRNA CEP-701 FIMM pan-cancer AAC -0.048 0.7
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.012 0.7
mRNA Sorafenib FIMM pan-cancer AAC -0.066 0.7
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.013 0.7
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.012 0.7
mRNA BIRB 0796 CTRPv2 pan-cancer AAC -0.014 0.7
mRNA nintedanib CTRPv2 pan-cancer AAC 0.013 0.7
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA linifanib GDSC1000 pan-cancer AAC -0.013 0.7
mRNA TW 37 GDSC1000 pan-cancer AAC 0.012 0.7
Download CSV